A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer

NCT02890511 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Stage IV Gastric Cancer

Interventions

DRUG: Paclitaxel

Sponsor

Daehwa Pharmaceutical Co., Ltd.